Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A little pRB can lead to big problems.

Philip W Hinds1

  • 1Author's Affiliation: Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine and Molecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts phil.hinds@tufts.edu.

Cancer Discovery
|July 9, 2014
PubMed
Summary

Germline deletion of the RB1 gene, which encodes the retinoblastoma tumor-suppressor protein pRB, increases cancer risk. Loss of one RB1 allele causes replication stress and aneuploidy, offering new therapeutic targets for tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deletion of MyD88 in T Cells Improves Antitumor Activity in Melanoma.

The American journal of pathology·2024
Same author

AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis.

Cancers·2023
Same author

AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis.

bioRxiv : the preprint server for biology·2023
Same author

A kinase-independent function of cyclin-dependent kinase 6 promotes outer radial glia expansion and neocortical folding.

Proceedings of the National Academy of Sciences of the United States of America·2022
Same author

AKT1 Is Required for a Complete Palbociclib-Induced Senescence Phenotype in BRAF-V600E-Driven Human Melanoma.

Cancers·2022
Same author

Hyperlipidemia-induced metabolic changes in regulatory T cells result in altered function.

European journal of immunology·2021

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The retinoblastoma tumor-suppressor protein (pRB), encoded by the RB1 gene, plays a critical role in cell-cycle control and preventing tumor formation.
  • Germline mutations in RB1 predispose individuals to retinoblastoma and other cancers, typically requiring loss of the remaining wild-type allele for tumor development.

Purpose of the Study:

  • To investigate the consequences of losing just one copy of the RB1 gene (haploinsufficiency) on cellular processes.
  • To explore the underlying mechanisms of RB1 haploinsufficiency and its implications for tumor initiation and treatment.

Main Methods:

  • Analysis of mouse and human cells with a single functional copy of the RB1 gene.
  • Assessment of cellular phenotypes including replication stress and aneuploidy.

Related Experiment Videos

Main Results:

  • Loss of a single RB1 allele leads to significant replication stress in both mouse and human cells.
  • Haploinsufficiency of RB1 results in aneuploidy, a hallmark of many cancer cells.
  • The study elucidates the mechanism by which RB1 haploinsufficiency contributes to a transformed cellular phenotype.

Conclusions:

  • Even a single functional copy of RB1 is crucial for maintaining genomic stability.
  • RB1 haploinsufficiency triggers cellular stress pathways that can promote tumor initiation.
  • Understanding these mechanisms may reveal novel therapeutic strategies for RB1-associated cancers and other tumors exhibiting similar defects.